In another study, Hartikainen et al. investigated the significance of NRF2 expression and its target gene sulfiredoxin (SRXN1) by using tissue microarrays representative of invasive breast carcinomas [57]. This evidence concerns the gene NFE2L2 and invasive breast carcinoma.